A Picture Is Worth a Thousand Targets | GenomeWeb

The BBC reports on new research describing the structure of telomerase, an enzyme long known to be implicated in tumor cells. The study, from scientists at the Wistar Institute in Philadelphia, "could lead to drugs which switch it off," the article says. The structural information could be key to providing molecular targets for therapeutics.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.